We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
-10.8%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$1.9B
AUM Growth
-$216M
Cap. Flow
+$51.8M
Cap. Flow %
2.73%
Top 10 Hldgs %
68.43%
Holding
55
New
7
Increased
8
Reduced
10
Closed
4

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$144M
2
CTLT
CATALENT, INC.
CTLT
+$133M
3
ACLX
Arcellx
ACLX
+$67.2M
4
CRM icon
Salesforce
CRM
+$64.3M
5
TSM icon
TSMC
TSM
+$53.7M

Top Sells

Rank Stock Value
1
EXAI
Exscientia Plc American Depositary Shares
EXAI
+$259M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$91.8M
3
AAPL icon
Apple
AAPL
+$51.8M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
+$17.4M
5
ZGNX
Zogenix, Inc.
ZGNX
+$7.19M

Sector Composition

Rank Sector Weight
1 Healthcare 48.98%
2 Technology 19.33%
3 Financials 8.72%
4 Consumer Discretionary 2.87%
5 Communication Services 1.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
26
Iovance Biotherapeutics
IOVA
$2.87B
$13.9M 0.73%
836,518
– –
BOLT icon
27
Bolt Biotherapeutics
BOLT
$7.78M
$12.3M 0.65%
225,200
– –
SILK
28
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$11.4M 0.6%
276,068
+128,511
+87% +$4.52M
NARI
29
DELISTED
Inari Medical, Inc. Common Stock
NARI
$11.2M 0.59%
123,122
+50,910
+71% +$4.17M
INSP icon
30
Inspire Medical Systems
INSP
$1.74B
$10.6M 0.56%
41,448
+5,948
+17% +$1.36M
SPNE
31
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$10.4M 0.55%
858,752
– –
LUNG icon
32
Pulmonx
LUNG
$87.6M
$10.2M 0.54%
410,155
+163,108
+66% +$4.21M
OKUR
33
OnKure Therapeutics
OKUR
$168M
$10.1M 0.53%
343,038
– –
RCKT icon
34
Rocket Pharmaceuticals
RCKT
$394M
$9.72M 0.51%
612,822
– –
TMCI icon
35
Treace Medical Concepts
TMCI
$309M
$9.46M 0.5%
500,421
– –
PHVS icon
36
Pharvaris
PHVS
$2.44B
$9.37M 0.49%
516,321
– –
CRNX icon
37
Crinetics Pharmaceuticals
CRNX
$8.92B
$9.33M 0.49%
+424,897
New +$8.6M
UTRS
38
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$9.22M 0.49%
102,445
-412
-0.4% -$41.9K
SPRB
39
Spruce Biosciences
SPRB
$129M
$9.07M 0.48%
60,191
– –
KNTE
40
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$7.03M 0.37%
624,236
+71,108
+13% +$783K
CMPI
41
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$6.9M 0.36%
2,161,990
-8,110
-0.4% -$23.3K
GRTX
42
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$5.85M 0.31%
2,459,021
– –
DMRA
43
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$5.5M 0.29%
99,912
– –
AKUS
44
DELISTED
Akouos Inc
AKUS
$5.04M 0.27%
1,061,990
– –
MQ icon
45
Marqeta
MQ
$1.66B
$4.88M 0.26%
110,390
– –
ALGS icon
46
Aligos Therapeutics
ALGS
$34.9M
$4.19M 0.22%
78,000
-26,583
-25% -$2.13M
ALNY icon
47
Alnylam Pharmaceuticals
ALNY
$29.3B
$4.08M 0.22%
25,000
– –
SPRO icon
48
Spero Therapeutics
SPRO
$73M
$4.08M 0.22%
468,902
– –
VRNA
49
DELISTED
Verona Pharma
VRNA
$3.8M 0.2%
761,205
– –
RLYB icon
50
Rallybio
RLYB
$85.8M
$3.04M 0.16%
+54,493
New +$4.51M
1
2
3

Similar funds

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.52% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return
SPC
Stony Point Capital New York $1.24B AUM 32.69% 1-Year Est. Return
SC
Strategy Capital Los Altos, California $1.22B AUM 27.02% 1-Year Est. Return

Novo Holdings A/S's Q1 2022 Portfolio in Review

As of Q1 2022, Novo Holdings A/S held 55 positions worth $1.9B, down 10% from $2.11B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Novo Holdings A/S's Q1 2022 filing shows 7 new, 8 increased, 10 reduced and 4 closed positions. Its largest new stake was ASML: 215,099 shares worth $144M. The largest sale was Exscientia Plc American Depositary Shares, an estimated $259M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 57% a quarter earlier, followed by Technology and Financials.

  • Novo Holdings A/S's largest Q1 2022 buy was ASML: 215,099 shares worth $144M.
  • Novo Holdings A/S added most to Silk Road Medical, Inc. Common Stock in Q1 2022, an estimated $4.52M increase.
  • Novo Holdings A/S's biggest Q1 2022 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $91.8M.
  • Novo Holdings A/S fully exited Exscientia Plc American Depositary Shares in Q1 2022, selling an estimated $259M.
  • Novo Holdings A/S's ten largest holdings make up 68% of its $1.9B portfolio in Q1 2022.
  • Novo Holdings A/S opened 7 new positions and closed 4 in Q1 2022.
  • Novo Holdings A/S's portfolio value fell 10% quarter-over-quarter to $1.9B.

Based on Novo Holdings A/S's 13F filing for Q1 2022, filed 16 May 2022.